Your healthcare provider may increase the dose to 1.5 mg weekly after at least four weeks if additional glycaemic control is needed, with further stepwise titration possible to 3.0 mg and then to a maximum of 4.5 mg weekly, with at least 4 weeks at each dose level
1 Fillerfy Semaglutide 30MG Lyophilized Powder
Clinical experience in Chinese populations will generate real-world data on long-term outcomes, side effects, and body composition changes that trial settings cannot fully capture
[1] Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal losses), and hypersensitivity reactions
After that, the dose is raised to 0.5 mg weekly , which works as the maintenance dose for many users